Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its IT Services and Public Sector Technology practices. Clearsight served as the exclusive advisor to Incapsulate, LLC (“Incapsulate” or the “Company”) in its acquisition by Accenture (NYSE: ACN). Incapsulate is a Washington, DC-based digital transformation consulting firm specializing in Salesforce solutions. Since its … Continued
Clearsight Advisors, Inc. (“Clearsight”) is pleased to share another successful transaction in its Healthcare and Life Sciences Practice. Clearsight served as exclusive financial advisor to Bionest Partners, Inc. (“Bionest” or the “Company”) in its acquisition by Accenture (NYSE: ACN). Bionest is an industry-leading life sciences consulting firm focused on commercialization, go-to-market strategy, and launch execution … Continued
Over the last 24 months, many perspectives have been shared regarding the staying power of ESG. Is it a craze or PR fad? Is it sustainable (pun intended)? More recently, the counter position has taken shape, characterizing ESG as a force, foundational and even mission critical. Wherever you fall on this spectrum – ESG has … Continued
On April 3rd, 2019, Accenture plc (NYSE:ACN), a global provider of consulting, technology, and outsourcing services, acquired Droga5, a global branding and marketing agency, for an undisclosed amount. Droga5 will be integrated with Accenture Interactive, boosting its capabilities as an experience agency able to ideate, design, build, and run customer experiences that grow purpose-led brands … Continued
Last month, Clearsight Advisors announced that we served as the exclusive strategic and financial advisor to Kogentix in its acquisition by Accenture. The global research and advisory firm 451 Research recently reported on that deal as an example of ballast for future M&A activity in the data science atmosphere, mentioning that “Accenture has also helped … Continued
